Axa lessened its position in shares of Cabot Corp (NYSE:CBT) by 97.5% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,700 shares of the specialty chemicals company’s stock after selling 142,070 shares during the quarter. Axa’s holdings in Cabot were worth $232,000 as of its most recent SEC filing.
A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in CBT. Bessemer Group Inc. grew its holdings in Cabot by 575.7% during the 3rd quarter. Bessemer Group Inc. now owns 2,034 shares of the specialty chemicals company’s stock valued at $128,000 after buying an additional 1,733 shares in the last quarter. Signition LP purchased a new position in Cabot during the 2nd quarter valued at approximately $234,000. Strs Ohio purchased a new position in Cabot during the 2nd quarter valued at approximately $349,000. Seven Eight Capital LP bought a new stake in shares of Cabot in the 3rd quarter valued at approximately $370,000. Finally, Commonwealth Bank of Australia bought a new stake in shares of Cabot in the 3rd quarter valued at approximately $401,000. Institutional investors and hedge funds own 86.43% of the company’s stock.
NYSE:CBT opened at $45.62 on Monday. The company has a market capitalization of $2.74 billion, a PE ratio of 11.32, a P/E/G ratio of 0.94 and a beta of 1.49. Cabot Corp has a 1 year low of $45.37 and a 1 year high of $68.63. The company has a debt-to-equity ratio of 0.56, a current ratio of 1.46 and a quick ratio of 0.92.
The firm also recently declared a quarterly dividend, which will be paid on Friday, December 14th. Investors of record on Friday, November 30th will be paid a dividend of $0.33 per share. This represents a $1.32 dividend on an annualized basis and a dividend yield of 2.89%. The ex-dividend date is Thursday, November 29th. Cabot’s dividend payout ratio is currently 32.75%.
CBT has been the subject of several analyst reports. ValuEngine lowered Cabot from a “hold” rating to a “sell” rating in a research note on Thursday, October 11th. Northcoast Research set a $75.00 price objective on Cabot and gave the company a “buy” rating in a research note on Wednesday, November 7th. Loop Capital set a $82.00 price objective on Cabot and gave the company a “buy” rating in a research note on Tuesday, November 6th. Barclays initiated coverage on Cabot in a research note on Monday, October 8th. They issued an “overweight” rating and a $76.00 price objective for the company. Finally, TheStreet lowered Cabot from a “b” rating to a “c+” rating in a research note on Friday, October 19th. Two equities research analysts have rated the stock with a sell rating and six have given a buy rating to the company’s stock. Cabot has an average rating of “Buy” and a consensus target price of $75.00.
TRADEMARK VIOLATION NOTICE: This piece of content was first reported by WKRB News and is the property of of WKRB News. If you are reading this piece of content on another publication, it was copied illegally and reposted in violation of US and international copyright & trademark law. The original version of this piece of content can be read at https://www.wkrb13.com/2018/12/10/cabot-corp-cbt-shares-sold-by-axa.html.
Cabot Corporation operates as a specialty chemicals and performance materials company. The company offers carbon black, a form of elemental carbon used to enhance the physical properties of the systems and applications in which it is incorporated; and rubber blacks for use as a rubber reinforcing agent and performance additive in tires, hoses, belts, extruded profiles, and molded goods.
Further Reading: What is a Swap?
Receive News & Ratings for Cabot Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cabot and related companies with MarketBeat.com's FREE daily email newsletter.